Ferritin Quantitative Test

SARS-CoV-2 Antigen Rapid Qualitative Test

The SARS-CoV-2 Antigen Rapid Qualitative Test is a colloidal gold immunochromatography intended for the qualitative detection of nucleocapsid antigens from SARS-CoV-2 in human nasal swabs, throat swabs, and sputum from individuals who are suspected of COVID-19 by their healthcare provider. within the first five days of the onset of symptoms.
Product Detail

Product Features

High sensitivity and specificity

Test results conveniently available in 20-30 minutes

Long shelf life of 24 months with room temperature storage

QR-code based patient tracking


Clinical Performance

Relative Sensitivity: 96.00% (88.75% - 99.17%)

Relative Specificity: 100.00% (98.34% - 100.00%)

Accuracy: 98.98% (97.06 – 99.79%)



Testing process for the SARS-CoV-2 Rapid Antigen Test

 

① Transfer 6 drops of extraction buffer to a tube.

② Insert the swab into an extraction buffer tube. While squeezing the buffer tube, stir the swab more than 10 seconds.

③ Remove the swab while squeezing the sides of the tube to extract the liquid from the swab.

④ Press the nozzle cap tightly onto the tube. Continue with 3a. Performing a test.

⑤ Place the test device on a flat surface and apply 2 drops of extracted sample in a 90° angle to the specimen well of the cassette

⑥ Read the test result at 20 to 30 mins.



Interpreting Test Results




Leave A Message

Please provide us with the information below, and we'll contact you as soon as possible.

Related Products
SARS-CoV-2 IgG/IgM Rapid Test
SARS-CoV-2 IgG/IgM Rapid Qualitative Test
The Biotime SARS-CoV-2 IgG/IgM Rapid Qualitative Test is intended to qualify the SARS-CoV-2 IgG and IgM antibody in human plasma, serum or whole blood by colloidal gold immunochromatography assay. The test can be used as an aid detection to SARS-CoV-2 infection and thus caused COVID-19 disease.
Neutralizing Antibody Rapid Test
SARS-CoV-2 Neutralizing Antibody Rapid Test
Biotime SARS-CoV-2 Neutralizing Antibody rapid test is a fluorescence immunoassay(FIA) for the qualitative detection of total neutralizing antibodies to SARS-CoV-2 in human serum or plasma. It is useful as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection.
PCT Rapid Quantitative Test (Chemiluminescence Immunoassay)
PCT Rapid Quantitative Test (Chemiluminescence Immunoassay)
PCT Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the Procalcitonin concentration in human serum, plasma that contains heparin /EDTA and other anticoagulants and venous whole blood samples, mainly used for auxiliary diagnosis of inflammation diseases.
biotime PGI PGII Rapid Quantitative Test
PGI/PGII Rapid Quantitative Test
Human pepsinogens I (PGI) and II (PGII) are proenzymes of pepsin—an endoproteinase of gastric juice. PGI is secreted mainly by chief cells in the fundic mucosa, whereas PGII is also secreted by the pyloric glands and the proximal duodenal mucosa. Serum PGI and PGII concentrations and the ratio between PGI and PGII may be related to the histologic and functional status of the gastric mucosa.
Incubation Chamber
ICE-100E Incubation Chamber
The incubation chamber is an auxiliary device for Biotime’s fluorescence immunoassay analyzer. The reaction temperature and time is critical for test results. The incubation chamber provides an optimized environment as well as automatic timers for test reactions to improve the reliability of test results.
Covid-19 Test
COVID-19 Ag & Flu A/B Combo Self Test
COVID-19 Ag & Flu A/B Combo Self Test is a colloidal gold immunochromatography intended for the in vitro rapid, simultaneous qualitative detection and differentiation of N protein from SARS-CoV-2, influenza A and influenza B directly from nasal swab specimens obtained from individuals, who are suspected of COVID-19, influenza A or influenza B infection. Results are for the simultaneous identification of N protein of SARS-CoV-2, influenza A and influenza B.
Biotime Myo Rapid Quantitative Test
Myo Rapid Quantitative Test
Myo is the earliest marker after AMI, and it is a sensitive and accurate indicator to judge whether there is reperfusion in thrombolytic therapy. Biotime Myo test kit is mainly used to detect Myo quantity in human serum and plasma samples.
Leave A Message

Leave A Message

    Please provide us with the information below, and we'll contact you as soon as possible.

Home

products

about

contact